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Abstract
Huntington’s disease (HD) is caused by expansion of a polyglutamine (polyQ) repeat in the 
huntingtin protein. A structural basis for the apparent transition between normal and disease-
causing expanded polyQ repeats of huntingtin is unknown. The ‘linear lattice’ model proposed 
random-coil structures for both normal and expanded polyQ in the preaggregation state. 
Consistent with this model, the affinity and stoichiometry of the anti-polyQ antibody MW1 
increased with the number of glutamines. An opposing ‘structural toxic threshold’ model proposed 
a conformational change above the pathogenic polyQ threshold resulting in a specific toxic 
conformation for expanded polyQ. Support for this model was provided by the anti-polyQ 
antibody 3B5H10, which was reported to specifically recognize a distinct pathologic conformation 
of soluble expanded polyQ. To distinguish between these models, we directly compared binding 
of MW1 and 3B5H10 to normal and expanded polyQ repeats within huntingtin exon 1 fusion 
proteins. We found similar binding characteristics for both antibodies. First, both antibodies bound 
to normal, as well as expanded, polyQ in huntingtin exon 1 fusion proteins. Second, an expanded 
polyQ tract contained multiple epitopes for antigen-binding fragments (Fabs) of both antibodies, 
demonstrating that 3B5H10 does not recognize a single epitope specific to expanded polyQ. 
Finally, small angle X-ray scattering and dynamic light scattering revealed similar binding modes 
for MW1 and 3B5H10 Fab-huntingtin exon 1 complexes. Together, these results support the linear 
lattice model for polyQ binding proteins, suggesting that the hypothesized pathologic 
conformation of soluble expanded polyQ is not a valid target for drug design.
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INTRODUCTION
Huntington’s disease (HD) is a fatal neurodegenerative disorder characterized clinically by 
psychiatric symptoms, cognitive decline, and uncontrolled movements [1]. HD is caused by 
expansion of a CAG repeat within exon 1 of HTT (previously HD) that encodes an expanded 
polyglutamine (polyQ) tract in the N-terminal portion of the huntingtin protein. A pathologic 
threshold exists for HD, in which HD is fully penetrant in patients with 42 or more 
glutamines in the huntingtin protein, but no disease is found in individuals with 36 or fewer 
glutamines, while huntingtin with 37 to 41 glutamines exhibits reduced HD penetrance [2]. 
Although a structural basis for an apparent normal-disease threshold is unknown, several 
hypotheses exist for the conformation of monomeric, soluble polyQ in normal and expanded 
huntingtin protein.
The ‘linear lattice’ hypothesis proposed that polyQ retains a random-coil structure for both 
normal and expanded polyQ in the preaggregation state. In this model, the increase in 
number of binding epitopes in expanded polyQ compared with normal polyQ results in 
avidity effects that cause higher apparent affinities for bivalent proteins such as antibodies 
[3]. This could induce altered binding interactions with other cellular proteins or other 
polyQ repeats, leading to neuronal toxicity. Consistent with this model, the affinity of the 
anti-polyQ antibody MW1 to huntingtin amino terminal protein encoded by exon 1 
(hereafter called huntingtin exon 1 protein) increased in a polyQ-length dependent manner, 
and binding of multiple antigen-binding fragments (Fabs) of MW1 to expanded polyQ tracts 
was observed. In addition, huntingtin exon 1 protein with 16 – 46 glutamines exhibited a 
random coil conformation in solution, and no evidence was found for a global conformation 
change above 37 glutamines [3, 4]. Surface plasmon resonance (SPR) and analytical 
ultracentrifugation (AUC) studies also demonstrated that multiple MW1 Fabs bound to 
expanded polyQ tracts [3]. The X-ray crystal structure of a GQ10G peptide bound to the 
variable regions of MW1 revealed that a short polyQ tract adopted an extended structure in a 
diagonal binding groove across the antigen-binding site of MW1 [4]. Additional binding 
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studies using the anti-polyQ antibody 1C2 [5] showed that 1C2 also exhibited preferential 
binding to expanded polyQ due to avidity effects, and this preferential binding was not due 
to a mutant huntingtin-specific toxic structure recognized by 1C2 [6].
In contrast, the ‘structural toxic threshold’ model proposed that a conformational transition 
occurs in polyQ repeats that are longer than the pathological threshold, which results in a 
specific toxic conformation for monomeric expanded polyQ that could potentially be 
recognized by antibodies [7]. According to this model, the postulated pathologic 
conformation could be directly toxic or it could alter interactions between mutant huntingtin 
and its binding partners; in either case, the pathologic conformation could be targeted for 
drug design. Support for this model was provided by studies of the anti-polyQ antibody 
3B5H10, which was reported to recognize a single epitope representing a distinct pathologic 
conformation of soluble expanded polyQ [8, 9]. In these studies, 3B5H10 IgG preferentially 
bound to expanded polyQ, and a two-stranded β-hairpin conformation of polyQ was 
modeled into the predicted polyQ-binding groove of the 3B5H10 Fab structure [9]. Support 
for this model was provided by a gel filtration assay of 3B5H10 Fab binding to a Q39-
containing huntingtin exon 1 fusion (HD-39Q) protein, which was interpreted to 
demonstrate a binding stoichiometry of 1:1 3B5H10 Fab:HD-39Q [8]. These results were 
suggested to indicate that 3B5H10 binds to a single structured polyQ epitope only present in 
expanded polyQ, as per the structural toxic threshold hypothesis. Modeling of small-angle 
X-ray scattering (SAXS) data was interpreted as showing that 3B5H10 Fab bound to 
HD-39Q in a 2:2 3B5H10 Fab:HD-39Q complex in which each 3B5H10 Fab recognized one 
subunit of an HD-39Q dimer through binding to a two-stranded β-hairpin conformation of 
polyQ [9]. Contradictory evidence was provided by a recent report demonstrating that pull-
down assays and surface plasmon resonance (SPR) studies showed that 3B5H10 IgG, like 
MW1 and 1C2 IgGs, could bind to short polyQ tracts, as expected given the high sequence 
and structural similarities between the three antibodies [6].
Here we compared the recognition properties of the anti-polyQ monoclonal antibodies MW1 
and 3B5H10 by studying their interactions with a polyQ-containing fragment of huntingtin. 
Using expressed and purified huntingtin exon 1-thioredoxin (TRX) fusion proteins 
containing 16 to 46 glutamines (HD-16Q, HD-25Q, HD-39Q, HD-46Q) (Fig. 1a), we 
directly compared the interactions between soluble huntingtin and these anti-polyQ 
antibodies using biochemical and biophysical analysis techniques. We found that both MW1 
and 3B5H10 antibodies exhibited similar binding properties, with neither providing 
evidence for a toxic conformation of expanded polyQ. These results argue against strategies 
designed to target a novel toxic conformation of soluble mutant huntingtin exon 1 protein in 
the preaggregation state.
RESULTS
Both MW1 and 3B5H10 antibodies bind to normal and expanded polyQ within huntingtin 
exon 1 proteins
Western blots were used to evaluate the binding of 3B5H10 and MW1 IgGs to equimolar 
amounts of huntingtin exon 1-TRX fusion proteins and to the TRX tag alone (Fig. 1b). If 
3B5H10 recognizes a toxic conformation present only in expanded polyQ, then unlike 
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MW1, it should not bind to short polyQ repeats. In contrast with some previous results [9], 
but consistent with other results [10, 11], we found that both MW1 and 3B5H10 IgGs bound 
in a similar manner to huntingtin exon 1 fusion proteins, each capable of binding to 
huntingtin exon 1 proteins containing both normal and expanded polyQ repeats. Both IgGs 
bound to huntingtin exon 1 proteins in a polyQ-dependent manner, with a progressively 
more intense signal with increased polyQ length. Based on these results, and previous 
western blots demonstrating the ability of 3B5H10 to bind to GST-polyQ with both short 
and long polyQ repeats [6], we conclude that both antibodies recognize a similar polyQ 
epitope that is present in both normal and expanded huntingtin exon 1 proteins.
In order to determine how it is possible to obtain results appearing to indicate that 3B5H10 
binds only to expanded polyQ, we examined binding of 3B5H10 and MW1 as a function of 
concentration to huntingtin exon 1 proteins with different polyQ repeat lengths. Dot blots of 
serial dilutions of huntingtin exon 1 proteins demonstrated that both 3B5H10 and MW1 
IgGs bound to huntingtin exon 1 proteins in a length- and concentration-dependent manner 
(Fig. 1c). At higher concentrations of huntingtin exon 1 protein, both IgGs recognized 
huntingtin exon 1 constructs with polyQ tracts ranging from Q16 to Q46. However, at lower 
concentrations of huntingtin exon 1 protein, a more intense signal was observed for the 
huntingtin exon 1 construct with the longest polyQ repeat (HD-46Q) compared to the 
construct with the shortest polyQ repeat (HD-16Q) (Fig. S1b,c). Due to the length- and 
concentration-dependent binding, conditions can be found in which MW1 or 3B5H10 IgG 
appeared to only bind expanded polyQ, thus explaining previously-reported results that 
3B5H10 only recognizes huntingtin with expanded polyQ [9]. However, for both antibodies, 
the binding dependence on polyQ length was progressive, without a distinct threshold at 
polyQ lengths >37Q. Thus, avidity effects resulted in bivalent IgG versions of 3B5H10 and 
MW1 showing preferential binding to expanded polyQ, as predicted by the linear lattice 
model for antibody interactions with polyQ repeats [3, 12].
Huntingtin exon 1 proteins are monomeric in solution
During purification of huntingtin exon 1 fusion proteins, we observed anomalous migration 
by gel filtration chromatography such that huntingtin exon 1 fusion proteins appeared to 
migrate as higher molecular weight proteins (e.g., dimers) when compared with molecular 
weight standards of globular proteins. To determine the oligomeric state of the huntingtin 
exon 1 fusion proteins, we used a combination of size-exclusion chromatography (SEC) 
with in-line multiangle light scattering (SEC-MALS), a technique that can be used to 
determine the absolute molecular mass of a protein or complex independent of shape and 
model [13]. To evaluate the methodology, we first analyzed 3B5H10 Fab alone, which 
migrated as a single monodisperse peak whose derived molecular mass closely matched the 
mass calculated from the amino acid sequence (Fig. 2; Table 1). HD-16Q and HD-39Q 
fusion proteins also migrated as monodisperse peaks, and their calculated molecular masses 
corresponded to monomers in each case (Table 1). Thus the anomalous migration of each 
huntingtin exon 1 protein in positions expected for a dimeric version of a globular protein of 
the same molecular mass results from slower migration due to an elongated structure rather 
than from dimerization. In particular, no evidence was found for dimer formation for 
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HD-39Q as predicted in a previous study involving the modeling of small-angle X-ray 
scattering (SAXS) data [9].
Non-equilibrium gel filtration chromatography analyses yield inconsistent apparent 
binding stoichiometries
We next replicated published non-equilibrium gel filtration chromatography experiments 
that were conducted to determine the stoichiometry of binding between 3B5H10 Fab and 
huntingtin exon 1 protein with an expanded polyQ repeat using the same proteins: 3B5H10 
Fab and HD-39Q [8]. By varying the ratio of 3B5H10 Fab to HD-39Q, we determined the 
ratio where the least amount of excess Fab or excess HD-39Q was detected, the method 
previously used to report a 1:1 3B5H10:HD-39Q binding stoichiometry [8]. Similar to the 
published results, we found that unbound 3B5H10 Fab was present at ratios greater than 1:1 
3B5H10 Fab:HD-39Q, unbound HD-39Q was present at ratios less than 1:1, and that the 
ratio where the least amount excess of Fab or excess HD-39Q could be detected was 1:1 
(Fig. 3a). As a control, we repeated the non-equilibrium gel filtration stoichiometry 
experiment to evaluate the binding behavior of MW1 Fab and HD-39Q (Fig. 3b), which was 
previously shown to form a complex with a greater than 1:1 stoichiometry [3]. Under non-
equilibrium conditions, the stoichiometry of MW1 Fab:HD-39Q appeared to be less than 
1:1. Thus it appeared that non-equilibrium gel filtration could not be reliably used to derive 
an accurate binding stoichiometry for an anti-polyQ Fab binding to huntingtin exon 1 fusion 
proteins with expanded polyQ.
However, we noted that with increasing molar ratios of 3B5H10 Fab:HD-39Q, the complex 
peak eluted earlier on the gel filtration column, suggesting that a complex larger than 1:1 
was forming at the same time as 3B5H10 Fab was dissociating from HD-39Q. Due to the 
anomalous migration of HD-39Q compared with globular proteins using gel filtration 
chromatography (see above), the molecular mass of the 3B5H10 Fab:HD-39Q complex peak 
could not accurately be estimated based on gel filtration migration. Using SEC-MALS, we 
found that the complex of 3B5H10 Fab and HD-39Q was polydisperse, and the molecular 
mass of the peak fraction corresponded to a complex composed of greater than a 1:1, but 
less than a 2:1, ratio of 3B5H10 Fab:HD-39Q (Table 1), demonstrating that dissociation of 
the complex occurred during the experiment. In contrast, the complex of 3B5H10 Fab and 
HD-16Q migrated as a monodisperse peak, and the calculated molecular mass for a 1:1 
3B5H10 Fab:HD-16Q stoichiometric ratio was in close agreement with the molecular mass 
obtained by SEC-MALS (Table 1).
Taken together, the results for these experiments suggested that binding stoichiometries for 
MW1 and 3B5H10 Fabs binding to huntingtin exon 1 proteins as determined by non-
equilibrium gel filtration are incorrect. This is likely because protein complexes that 
dissociate during this procedure are unable to rebind due to separation by the gel filtration 
column. Therefore depending on the binding kinetics and the amount of separation between 
anti-polyQ Fabs and huntingtin exon 1 proteins on the gel filtration column, the binding 
stoichiometries determined by non-equilibrium gel filtration techniques may be artificially 
low, as has been found in other protein-protein interaction systems evaluated by this 
technique [14, 15].
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Expanded polyQ tracts within huntingtin exon 1 proteins contain multiple epitopes for the 
antigen-binding fragments (Fabs) of MW1 and 3B5H10
To determine an accurate stoichiometry of binding between HD-39Q and the Fabs of 
3B5H10 and MW1, we used equilibrium gel filtration [16]. In this technique, a 
chromatography column is run with an equilibration buffer containing one of the binding 
partners (e.g., protein A). Different ratios of the binding partners (e.g., protein A and protein 
B) are then injected onto the column. When the amount of additional protein A injected is 
less than that required for formation of a complex, a trough will form at the position that 
protein A migrates. If the amount of additional protein A injected is in excess for complex 
formation, a peak is observed at the position that protein A migrates. When the amount of 
additional protein A injected is at the amount required for complex formation, a flat baseline 
is observed at the position that protein A migrates. However, unless the protein 
concentration in the equilibration buffer is much greater than the affinity of the protein-
protein complex, the ratio of protein A to protein B at which a flat baseline is observed will 
not be an integer, in which case the correct stoichiometry can be obtained by rounding up to 
the next integer [14] or by Scatchard analysis [15]. Previous measurements demonstrated a 
higher polyQ binding affinity for 3B5H10 Fab than for MW1 Fab: KD = 1.0 μM for 3B5H10 
Fab binding to a Q22 or Q41 peptide [6] versus KD = 2.2 μM for MW1 Fab binding to 
HD-39Q [3]. Therefore we used higher concentrations of MW1 Fab (1–10 μM) than 
3B5H10 Fab (0.5–5 μM) in these experiments.
Complexes containing different ratios of Fab and HD-39Q were incubated together and 
injected onto a gel filtration column equilibrated with the appropriate Fab. A series of 
experiments with different concentrations of 3B5H10 Fab in the equilibration buffer were 
performed. For example, for 5 μM of 3B5H10 Fab in the equilibration buffer, the 
stoichiometry at which no peak or trough was observed was ~2.6:1 (Fig. 4a). Analysis with 
MW1 Fab yielded similar results, with the MW1 Fab:HD-39Q stoichiometry approaching 
3:1 (Fig. 4b). Therefore for both antibodies, the stoichiometry of binding was determined as 
3:1 Fab:HD-39Q.
Dynamic light scattering (DLS) revealed similar sizes for complexes of MW1 and 3B5H10 
Fabs with huntingtin exon 1 proteins
To further investigate complexes of anti-polyQ Fabs bound to huntingtin exon 1 proteins, 
we used dynamic light scattering (DLS) to compare hydrodynamic radii (Rh) of 3B5H10 and 
MW1 Fabs alone, HD-16Q and HD-39Q alone, and complexes of Fab and huntingtin exon 1 
protein. Fab complexes with HD-16Q were prepared at a 1:1 Fab:HD-16Q molar ratio, while 
complexes with HD-39Q were prepared at a 3:1 molar ratio. Concentrations of proteins and 
complexes varied from 1–7 mg/mL, higher than the concentrations used for equilibrium gel 
filtration experiments. As expected, the Rh values derived for the 3B5H10 and MW1 Fabs, 
which are globular proteins of similar dimensions, were roughly the same, and both Rh 
values were smaller than the Rh values for HD-16Q and HD-39Q (Table 2), consistent with 
the proposed elongated structures of HD-16Q and HD-39Q [3] (Table 2). Notably, the Rh 
value for HD-16Q was smaller than for HD-39Q, inconsistent with the compact structure 
proposed for expanded polyQ [9]. When complexed with huntingtin exon 1 proteins, both 
Fabs exhibited qualitatively similar behavior: the Rh values were lower for the Fab 
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complexes with HD-16Q than with HD-39Q. Based on our gel filtration and SEC-MALS 
data (Fig. 2,4), the complexes being examined by DLS were likely to be 1:1 Fab:HD-16Q 
complexes and a mixture of 2:1 and 3:1 Fab:HD-39Q complexes for both Fabs. Consistent 
with our other results, the 3B5H10 and MW1 Fabs did not exhibit different properties when 
binding to huntingtin exon 1 proteins as would have been expected if 3B5H10, but not 
MW1, recognized a pathologic conformation of expanded polyQ.
Small-angle X-ray scattering revealed similar predicted characteristics for complexes of 
MW1 and 3B5H10 Fabs with huntingtin exon 1 proteins
We next repeated published small-angle X-ray scattering (SAXS) studies for HD-39Q alone 
and complexed with 3B5H10 Fab [9], comparing results with SAXS data for analogous 
complexes with MW1 Fab and HD-16Q. We collected SAXS data for samples of 3B5H10 
and MW1 Fabs alone, HD-16Q, HD-25Q, HD-39Q, and HD-46Q alone, and complexes of 
each Fab with HD-16Q and HD-39Q. With the exception of the HD-46Q alone sample, the 
scattering profiles for the Fabs, huntingtin exon 1 fusion proteins alone, and Fab:HD-16Q 
and Fab:HD-39Q complexes showed ideal sample quality characteristics (Fig. S2). Guinier 
analysis [17] indicated minimal aggregation for both Fabs alone and Fabs complexed with 
HD-16Q and HD-39Q and for all huntingtin exon 1 fusion proteins alone (Fig. S3). Radii of 
gyration (Rg) determined by SAXS were consistent with Rh values determined by DLS 
(Table 2). In particular, for measurements of huntingtin exon 1 fusion proteins alone, we did 
not see substantially increased Rh or Rg values for HD-39Q compared with HD-16Q, 
consistent with computational modeling of polyQ in aqueous solution suggesting that radii 
of polyQ tracts of increasing lengths are similar [18], but inconsistent with the structural 
toxic threshold model predicting a conformational transition for expanded polyQ tracts [9]. 
The predicted molecular weights of the complexes of 3B5H10 or MW1 Fab bound to 
HD-16Q in a 1:1 complex were similar to the molecular weights calculated based on the 
extrapolated scattering intensity at zero angle [19]. However, 3B5H10 Fab or MW1 Fab 
bound to HD-39Q formed complexes with observed molecular weights larger than a 1:1 
complex. Based on molecular weight alone, these complexes could be 2:1, 3:1, or 2:2 
Fab:HD-39Q complexes. A 2:2 3B5H10 Fab:HD-39Q stoichiometry was postulated to 
account for previous SAXS data [9]. However, our SEC-MALS and equilibrium gel 
filtration data demonstrated that 3B5H10 Fab does not bind to HD-39Q in a 2:2 ratio (Fig. 
2). Therefore, we interpret our SAXS data for both 3B5H10 and MW1 Fab binding to 
HD-39Q as evidence for mixtures of 2:1 and 3:1 Fab:HD-39Q complexes.
Kratky analysis was used to evaluate the relative degree of folding of each sample [20]. The 
Kratky plots for MW1 and 3B5H10 Fabs alone yielded bell-shaped peaks consistent with 
globular proteins [21, 22] (Fig. 5a). By contrast, the Kratky plots for HD-16Q and HD-39Q 
were broader, with less degrease at higher scattering angles, consistent with flexible or 
unfolded proteins [21, 22] (Fig. 5b). Thus we found no evidence for a conformational 
change occurring for HD-39Q relative to HD-16Q. Similarly, we found no systematic 
differences for 3B5H10 versus MW1 Fab complexes with either HD-16Q or HD-39Q (Fig. 
5c,d). These results are consistent with both Fabs exhibiting similar recognition properties 
for polyQ tracts.
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Three-dimensional structures can be modeled into SAXS profiles; however, modeling is 
limited by the one-dimensional nature of SAXS data, and more than one 3-D shape can 
produce the same one-dimensional scattering profile [23]. We did not attempt to fit atomistic 
models into the SAXS data as done in a previous study [9] because (i) the complete 3-D 
structure of huntingtin exon 1 protein is unknown, (ii) the polyQ tract within huntingtin exon 
1 fusion proteins adopts flexible random coil structures in solution [3], and (iii) the 
arrangements between polyQ tracts, the remainder of huntingtin exon 1, the TRX fusion 
partner, and the His purification tag cannot be predicted. Nor did we assume that the 
huntingtin exon 1 fusion proteins were dimeric, as also done for interpretation of SAXS data 
involving HD-39Q bound to 3B5H10 Fab [9], because our SEC-MALS data demonstrated 
that HD-39Q is monomeric in solution (Fig. 2). Instead, we used minimal assumptions to 
generate ab initio models that predicted molecular envelopes from the SAXS data for each 
of the well-behaved samples. We did not find notable differences between 3B5H10:HD-39Q 
and MW1:HD-39Q complexes based on Rg, Dmax, or shape or volume of calculated 
envelopes (Fig. 6, Table 2), as would be predicted by the toxic conformation model 
suggesting that 3B5H10, but not MW1, recognizes a compact conformation of expanded 
polyQ [9]. Instead, in agreement with experiments described above and in previous reports 
[3, 4, 6, 12], the SAXS results were consistent with recognition of multiple epitopes within a 
linear lattice of expanded polyQ by both Fabs.
DISCUSSION
The structure of huntingtin exon 1 protein in the preaggregation state, particularly the 
conformation of the expanded polyQ repeat, is hypothesized to be critical in understanding 
the pathogenesis of HD. However, the structure of the basic components of huntingtin exon 
1 remains controversial. An X-ray crystal structure of a Q17 huntingtin N-terminal region 
fused to MBP showed that a short polyQ region could adopt either α-helical, loop, or 
random coil conformations [24]. The structure of a Q10 peptide bound to the anti-polyQ 
antibody MW1 revealed an extended structure [4]. Other recent work suggested that the 
polyQ repeat acts as a flexible hinge that exhibits reduced flexibility at extended polyQ 
lengths [25]. In the present study, we show that the binding properties of the anti-polyQ 
antibodies MW1 and 3B5H10 support the ‘linear lattice’ model for the structure of soluble 
polyQ in the context of a huntingtin exon 1 fusion protein. This model postulates that both 
normal and expanded polyQ tracts in the preaggregation state are random-coil structures, 
with expanded polyQ repeats containing more epitopes recognized by antibodies or other 
binding proteins than normal polyQ tracts [3]. Several lines of evidence, reported here and 
in previous publications [6, 11], have shown that 3B5H10 and MW1 IgGs can bind to a 
normal polyQ repeat, demonstrating that neither antibody preferentially recognizes a novel 
structure formed by expanded polyQ, but instead both recognize a short stretch of polyQ. 
This conclusion is in contrast to other studies suggesting that 3B5H10 bound preferentially 
to expanded polyQ repeats of mutant huntingtin according to a ‘structural toxic threshold’ 
model, in which a conformational transition occurs in the polyQ repeat of huntingtin exon 1 
protein at the pathologic threshold (>37Q) [9]. Instead our results agree with the conclusions 
of a recent study comparing the binding of anti-polyQ antibodies 1C2 and 3B5H10 to polyQ 
repeats [6].
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To evaluate whether an expanded polyQ tract contains one epitope for anti-polyQ Fabs as 
predicted by the structural toxic threshold model, or multiple epitopes for the Fabs as 
predicted by the linear lattice model, we evaluated complexes using equilibrium gel 
filtration chromatography. Our results demonstrated that the stoichiometry of both 3B5H10 
Fab:HD-39Q and MW1 Fab:HD-39Q complexes was ~3:1 Fab:HD-39Q for both Fabs, thus 
neither Fab preferentially recognizes a novel structure formed by expanded polyQ. 
Consistent with this result, we confirmed that both 3B5H10 and MW1 IgGs recognized 
unexpanded polyQ, in direct contradiction to the structural toxic threshold model. We also 
used SAXS and DLS to further study the conformation of normal and expanded forms of 
huntingtin exon 1 protein, alone and in complex with MW1 or 3B5H10 Fab. This allowed us 
to determine the globularity of the protein complexes and their approximate oligomeric 
states, which revealed striking similarities between MW1 and 3B5H10 Fabs, both when 
unliganded and when bound to HD-16Q or HD-39Q. Thus a combination of equilibrium gel 
filtration chromatography, DLS, and SAXS data are consistent with a linear lattice mode of 
recognition of unstructured polyQ for both 3B5H10 and MW1 antibodies. Sharing the same 
general ligand-binding properties is consistent with the high degree of sequence and 
structural similarity relating 3B5H10 and MW1 [6]: the variable regions are related by 53% 
(VH domain) and 99% (VL domain) sequence identity and a root mean square deviation of 
0.59 Å for superposition of VH-VL regions of the 3B5H10 (PDB code 3S96) and MW1 
(PDB code 2GSG) crystal structures (calculated for all Cα atoms). In addition, the antigen-
binding sites of both antibodies include an unusual diagonal groove [6] shown to 
accommodate a single extended stretch of polyQ in an MW1-polyQ co-crystal structure [4], 
and thus unlikely to bind to a two-stranded β-hairpin structure of polyQ, as modeled for the 
HD-39Q interaction with 3B5H10 Fab [9].
Reduced penetrance is seen in patients with between 37 and 41 glutamine repeats in the 
huntingtin protein, which may be best explained by a quantitative change in a rate-limiting 
process in which the effects can be countered in some patients and not in others due to 
environmental or genetic modifiers. This reduced penetrance is consistent with a continuous 
linear lattice effect that is weak at lower polyQ repeat lengths and progressively stronger at 
larger repeat lengths. These results are relevant to potential therapeutic approaches to target 
soluble expanded polyQ in a lag period preceding aggregation. As we find no evidence for 
recognition of a specific conformation of expanded polyQ within huntingtin exon 1 proteins 
in either this study or previous studies [3, 4, 6, 12], we suggest that efforts to target 
expanded polyQ using monomeric binding partners are unlikely to be successful in 
discriminating polyQ stretches found in non-disease proteins such as transcription factors 
[26, 27] from expanded polyQ within mutant huntingtin exon 1. Instead, we suggest 
strategies in which reagents that recognize short stretches of polyQ are covalently linked to 
allow avidity effects to discriminate between short and expanded polyQ tracts.
MATERIALS AND METHODS
Protein expression and purification
Human huntingtin exon 1 encoded protein (comprising 91 amino acids when containing 16 
glutamine residues) including different sized polyQ segments (Q16, Q25, Q39, and Q46) 
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coded for by CAG or CAA/CAG repeats was expressed as a fusion protein with thioredoxin 
(TRX). Exon 1 fusion proteins were purified as previously described [3] with the following 
modifications: autoinduction was used to culture cells to high densities [28], and sonication 
was used for cell lysis. Purified proteins were flash frozen and stored at −80°C in 50 mM 
Tris (pH 8.0) and 150 mM NaCl.
MW1 IgG2b was purified from ascites fluid by protein A affinity chromatography (GE 
Healthcare). MW1 Fab was prepared by papain cleavage of MW1 IgG using a ratio of 1:25 
(papain:MW1 by weight) for 30 minutes at 37°C. Fabs were separated from the Fc fragment 
using protein A affinity chromatography (GE Healthcare) and then further purified by gel 
filtration chromatography (Superdex 200 10/300 GL).
3B5H10 Fab was expressed and purified as previously described for other IgGs [29]. 
Briefly, the 3B5H10 light chain (LC) gene and a C-terminally 6x-His tagged heavy chain 
(HC) gene were subcloned separately into the pTT5 mammalian expression vector (NRC 
Biotechnology Research Institute), and 3B5H10 Fab was expressed by transient co-
transfection of HEK293-6E (NRC Biotechnology Research Institute) cells and purified from 
supernatants using Ni2+-NTA affinity chromatography and gel filtration chromatography 
(Superdex 200 10/300 or 16/60).
Protein concentrations were determined using 280 nm extinction coefficients of 80,830 M−1 
cm−1 (3B5H10 Fab), 78,310 M−1 cm−1 (MW1 Fab), 14,180 M−1 cm−1 (TRX), 14,180 M−1 
cm−1 (HD-16Q), and 14,180 M−1 cm−1 (HD-39Q). Extinction coefficients were calculated 
based on amino acid sequence using ProtParam (http://web.expasy.org/protparam/protpar-
ref.html).
Western and dot blot analyses
Equimolar amounts of purified huntingtin exon 1 protein and TRX were loaded and 
separated on an Any kD Mini-PROTEAN gel (Bio-Rad Laboratories, Hercules, CA) at 175 
V for 40 minutes, followed by transfer to a nitrocellulose membrane at 100 V for 1 hour. 
After blocking for 1 hour in TBST with 3% BSA, membranes were incubated overnight at 
4°C with 3B5H10 IgG (Sigma, St. Louis, MO), MW1 IgG (purified from ascites), or rabbit 
polyclonal N17 huntingtin IgG [30] at 1:75,000 or, 1:10,000, or 1:7,500 respectively. 
Membranes were washed with TBST and incubated with HRP-conjugated anti-mouse IgG 
(Jackson Immunoresearch Laboratories, West Grove, PA) or HRP-conjugated anti-rabbit 
IgG (Jackson Immunoresearch Laboratories) for 1 hour at room temperature. Membranes 
were washed again, and antibody binding was detected using Amersham Enhanced 
Chemiluminescence (ECL) Prime Western Blotting Detection Reagent (GE Life Sciences, 
Uppsala, Sweden). Western blots were imaged using a ChemiDoc MP Imaging System 
(Bio-Rad Laboratories). Equimolar amounts of purified huntingtin exon 1 protein and TRX 
were also analyzed by SDS-PAGE on an Any kD Mini-PROTEAN gel (Bio-Rad 
Laboratories) and stained with Coomassie.
Equimolar amounts of huntingtin exon 1 fusion protein and TRX were serially diluted in 50 
mM Tris (pH 8.0), 150 mM NaCl and spotted onto nitrocellulose membranes. Membranes 
were washed with TBST and probed with 3B5H10, MW1, or mouse monoclonal anti-TRX 
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(Genscript, Piscataway, NJ) IgGs overnight at 4°C. HRP-conjugated goat anti-mouse 
secondary antibody (Jackson Immunoresearch Laboratories) was used to quantitate antibody 
binding to proteins on the membrane, and antibody binding was detected using Amersham 
ECL Prime Western Blotting Detection Reagent (GE Life Sciences). Densitometry of blots 
was performed using Image Lab 5.2.1 Software (Bio-Rad Laboratories). Densities were 
expressed as a ratio relative to the density observed for HD-16Q (western blots) or 20 pmol 
HD-16Q (dot blots).
SEC-MALS
Purified proteins or protein complexes were characterized by SEC-MALS to determine 
absolute molecular masses [13]. Proteins were concentrated to 1 mg/mL, passed through a 
0.2 μm filter (Millipore), and injected onto a Superdex 200 10/300 GL gel-filtration 
chromatography column equilibrated in a buffer containing 20 mM Tris (pH 8.0) and 100 
mM NaCl. The chromatography system was connected with an 18-angle light-scattering 
detector (DAWN HELEOS II; Wyatt Technology), a dynamic light-scattering detector 
(DynaPro Nanostar; Wyatt Technology), and a refractive index detector (Optilab t-rEX; 
Wyatt Technology). Data were collected every second at a flow rate of 0.5 mL/min at 25°C. 
Data analysis was carried out using the program ASTRA 6, yielding the molar mass and 
distribution of mass (polydispersity) of the sample.
Non-equilibrium gel filtration chromatography
Non-equilibrium protein interaction experiments were carried out on a Superdex 200 PC 
3.2/30 gel-filtration column (GE Healthcare) equilibrated in a buffer containing 50 mM Tris 
(pH 8.0) and 150 mM NaCl. A final concentration of 7 μM HD-39Q was used for all 
experiments, with 3B5H10 and MW1 Fab concentrations varied to create Fab:HD-39Q 
complexes with final molar ratios of 0.25:1, 0.5:1, 1:1, 1.5:1, 2:1, and 3:1. 50 μL of each 
complex was injected and flowed through the column at 50 μL/min at room temperature. 
The absorbance of the eluent was monitored at 280 nm.
Equilibrium gel filtration chromatography
A Superdex 200 PC 3.2/30 (GE Healthcare) gel filtration column was equilibrated and run 
with equilibration buffer: 50 mM Tris (pH 8.0), 150 mM NaCl and a specific concentration 
of 3B5H10 Fab (0.5 μM, 0.75 μM, 1 μM, or 5 μM) or MW1 Fab (1 μM, 3 μM, 5 μM, or 10 
μM). Complexes containing 0:1, 1:1, 2:1, or 3:1 molar ratios of a variable concentration of 
Fab:HD-39Q, where the concentration of HD-39Q was equal to the concentration of Fab in 
the equilibration buffer, were incubated for 30 minutes at room temperature in equilibration 
buffer and then injected onto the column. Chromatography was performed at a flow rate of 
50 μL/min using a SMART micropurification system (Pharmacia), and the absorbance of the 
eluent was monitored at 280 nm.
Dynamic light scattering (DLS)
DLS measurements were conducted on a DynaPro® NanoStar™ (Wyatt Technology, 
Goleta, CA) at 25°C. All samples were purified using a Superdex 200 10/300 column in 50 
mM Tris (pH 8.0), 150 mM NaCl prior to DLS and SAXS measurements, and the same 
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sample preparations were used for both experiments. Fractions were pooled and 
concentrated to at least 2 mg/mL and filtered through 0.2 μm membranes (Millipore). 
Samples were equilibrated to 25°C prior to DLS measurements. Data were analyzed using 
Dynamics V7.1.2 software (Wyatt Technology) to calculate hydrodynamic radii (Rh).
Small angle X-ray scattering (SAXS)
Small angle X-ray scattering experiments were conducted at beamline 4-2 at SSRL using a 
Rayonix MX225-HE detector at a distance of 2500 mm, using 1.13 Å wavelength X-rays. 
Protein preparations for DLS measurements were used for SAXS data collection. For each 
protein or complex, scattering intensity was measured at four protein concentrations (0.5–7 
mg/mL), collecting 10 exposures of 1 second each, covering a momentum transfer (q) range 
of 0.0047–0.375 1/Å. The scattering profile for the buffer was obtained in the same manner. 
Scattering curves collected from protein samples were corrected for background scattering 
using the intensity data collected from the buffer alone using SasTool [31].
SAXS scattering curves were scaled, high and low q regions of scattering curves were 
merged to extrapolate to infinite dilution, and Guinier analysis was performed using 
PRIMUS [32]. Rg values were calculated from Guinier plots. Scattering curves were 
overlaid to check for concentration-dependent effects on the scattering profile. GNOM [17] 
was used to calculate pairwise distribution functions. Porod volumes were calculated from 
DATPOROD [33]. Molecular weight was calculated by using the formula MMp = I(0)p/
cp*(MMst)/(I(0)st/cst), where MMp and MMst are molecular masses of the protein and 
lysozyme standard, respectively, I(0)p and I(0)st are the scattering angles at zero intensity, 
and cp and cst are the concentrations [19]. The protein concentration, cp, was calculated 
using the equation A = ε L cp, where A is absorbance at 280 nm, ε is the molar extinction 
coefficient, and L is the path length. The extinction coefficient and theoretical molecular 
weight for a 3:1 and a 1:1 Fab:huntingtin exon 1 protein complex are different. Because we 
most likely observed a mixture of 1:1, 2:1, and 3:1 Fab:huntingtin complexes, we listed a 
lower limit (100% 1:1) and upper limit (100% 3:1) for potential complex sizes.
For each protein or complex, at least 10 ab initio models were generated using DAMMIF 
[34]. Models were superimposed and averaged using DAMMIN [35] and DAMAVER [36] 
in the ATSAS package [33], and resulting models were filled with dummy atoms.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ABBREVIATIONS
AUC analytical ultracentrifugation
CDR complementarity determining region
Fab antigen-binding fragment
HC heavy chain
HD Huntington’s disease
LC light chain
MALS multiangle light scattering
polyQ polyglutamine
Rg radius of gyration
Rh hydrodynamic radius
SAXS small angle X-ray scattering
SEC size-exclusion chromatography
SPR surface plasmon resonance
SSRL Stanford Synchrotron Radiation Lightsource
TRX thioredoxin
VH heavy chain variable domain
VL light chain variable domain
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HIGHLIGHTS
• We assessed binding of MW1 and 3B5H10 anti-polyQ monoclonal antibodies 
and Fabs to normal and expanded huntingtin exon 1 polyQ repeats.
• Western and dot blots revealed binding of MW1 and 3B5H10 IgGs to both short 
and expanded polyQ tracts in huntingtin exon 1 fusion proteins.
• Equilibrium gel filtration studies showed that multiple MW1 or 3B5H10 Fabs 
bound to a huntingtin exon 1 fusion protein with 39 glutamines.
• Selectivity of antibodies for specific conformations of polyQ to distinguish 
species of huntingtin exon 1 fusion protein was not observed, and no evidence 
for a conformational transition between soluble wild type and mutant huntingtin 
exon 1 was found.
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Fig. 1. 
Biochemical analyses of huntingtin exon 1:3B5H10 IgG and huntingtin exon 1:MW1 IgG 
complexes. (a) Schematic of organization of human huntingtin exon 1- thioredoxin (TRX) 
fusion proteins used in this study. The bar above the domain structure represents the 
huntingtin exon 1 fragment with the polyQ tract indicated by a bracket. N17, N-terminal 17 
amino acid domain. PRR, proline rich region. (b) Western blot analysis of 3B5H10 and 
MW1 IgG binding to huntingtin exon 1 fusion proteins with variable numbers of glutamines. 
Both MW1 and 3B5H10 IgGs bound to huntingtin exon 1 proteins with normal and 
expanded polyQ repeats, but did not bind the TRX-tag control (top panels). Equimolar 
loading of huntingtin exon 1 fusion proteins was verified by blotting with the N17 antibody 
that recognizes the first 17 residues of huntingtin [30] (bottom panel). Densitometry of 
bands in blots is shown in Fig. S1b. (c) Dot blot analysis of 3B5H10 and MW1 IgG binding 
to huntingtin exon 1 fusion proteins (top panels). Equimolar loading of huntingtin proteins 
was verified by blotting with anti-TRX (bottom panel). Densitometry results are shown in 
Fig. S1c. As huntingtin concentrations decreased, binding to short polyQ repeats of 
huntingtin exon 1 protein was reduced more than binding to long polyQ repeats for both 
anti-polyQ antibodies MW1 and 3B5H10.
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Fig. 2. 
SEC-MALS profiles of huntingtin exon 1 protein and Fab:huntingtin exon 1 complexes. 
Complexes were prepared with ~3-fold molar excess of Fab for experiments with HD-39Q 
and ~equal molar ratios for experiments with HD-16Q and then injected onto a Superdex 
200 10/300 GL gel filtration column. The differential refractive index (left axis) is plotted 
against elution time from a gel filtration column and overlaid with the molar mass 
determined for each peak (right axis).
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Fig. 3. 
Non-equilibrium gel filtration chromatography analyses of Fab:HD-39Q complexes. Fabs of 
MW1 or 3B5H10 and HD-39Q were incubated at Fab:HD-39Q molar ratios of 0.25:1, 0.5:1, 
1:1, 1.5:1, 2:1, and 3:1, and passed over a gel filtration column run under non-equilibrium 
conditions. An HD-39Q concentration of 7 μM was used for all experiments. (a) 3B5H10 
Fab in complex with HD-39Q. (b) MW1 Fab in complex with HD-39Q.
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Fig. 4. 
Equilibrium gel filtration chromatography analyses of Fab:HD-39Q complexes. MW1 or 
3B5H10 Fabs and HD-39Q were incubated at the indicated molar ratios and passed over a 
gel filtration column run in an equilibration buffer containing the indicated concentrations of 
3B5H10 or MW1 Fab. For each experiment, HD-39Q at the same concentration as the Fab 
in the equilibration buffer was incubated with Fab at Fab:HD-39Q molar ratios of 0:1, 1:1, 
2:1, and 3:1 in the equilibration buffer and injected onto a column that had been equilibrated 
in the equilibration buffer. The peak eluting first corresponds to a Fab:HD-39Q complex. 
The second peak or trough occurs at the volume where free Fab elutes. (a) 3B5H10 Fab in 
complex with HD-39Q using 0.5 μM, 0.75 μM, 1.0 μM, and 5 μM 3B5H10 Fab in the 
equilibration buffer. (b) MW1 Fab in complex with HD-39Q using 1 μM, 3 μM, 5 μM, and 
10 μM MW1 Fab in the equilibration buffer. The stoichiometry approached 3:1 
Fab:HD-39Q for both Fabs.
Owens et al. Page 20
J Mol Biol. Author manuscript; available in PMC 2016 July 31.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 5. 
Kratky plot analyses of SAXS data for huntingtin exon 1 fusion proteins, MW1 and 3B5H10 
Fabs, and complexes of Fabs and huntingtin exon 1 proteins. Each plot shows the intensity 
of scattering plotted as Iq2 versus q, where q is scattering angle (Å−1) and I is the scattering 
intensity. (a) For MW1 and 3B5H10 Fabs, each plot exhibited one maximum, indicating that 
these are globular proteins. (b) HD-16Q and HD-39Q showed a plateau at higher q values, 
suggesting that these proteins include disordered regions, with decreasing globular character 
as the polyQ repeat length increased. (c) Curves for 3B5H10:HD-16Q and MW1:HD-16Q 
complexes were similar, each exhibiting broad single peaks. (d) Curves for 
3B5H10:HD-39Q and MW1:HD-39Q complexes were similar, each exhibiting a similar low 
plateau.
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Fig. 6. 
Ab initio models derived from SAXS data for huntingtin exon 1 fusion proteins, MW1 and 
3B5H10 Fabs, and Fabs:huntingtin exon 1 complexes. Calculated molecular envelopes filled 
with dummy atoms reveal the shapes of (a) 3B5H10 Fab, MW1 Fab, HD-16Q, HD-39Q, (b) 
3B5H10 Fab:HD-16Q, MW1 Fab:HD-16Q, 3B5H10 Fab:HD-39Q, MW1 Fab:HD-39Q.
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Table 1
SEC-MALS analysis of huntingtin exon 1 proteins and 3B5H10 Fab:huntingtin exon 1 complexes. The 
observed and calculated molecular masses of the proteins are listed.
Molecule or complex SEC-MALS Molecular Mass (kDa)
Observed Calculated
HD-16Q 23.1 24.3
HD-39Q 24.3 27.2
3B5H10 Fab 44.7 48.1
HD-16Q + 3B5H10 Fab 63.0 72.4 (1:1)
HD-39Q + 3B5H10 Fab 110.3 75.3 (1:1)
123.5 (2:1)
171.5 (3:1)
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